Total Funding
90
51
Total FundingVenture - Series Unknown raised
Growth Score 90 in past quarter
-4 pts
Heat Score 51 in past quarter
-39 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
85159
Praeventix is a biotechnology company developing therapeutics to treat bowel diseases.
- Douglas Pippin: President & CEO
- Heidi Kempinski: CEO
About the Company
Praeventix is an early-stage biotechnology company developing therapeutics to treat bowel diseases. It engages in and focuses on the discovery, research, and early clinical development of novel serotonergic therapeutics with potential applications in dermatologic, autoimmune, and neurodegenerative diseases.